Obstructive Sleep Aponea (moderate to severe) and Overweight
Upcoming
-
Adelaide SA
Efficacy and Safety of a new medication in Participants with Obstructive Sleep Apnea and Obesity or Overweight who are not diabetic
- Age > 18 years
- Known moderate to severe OSA (free repeat sleep study during screening)
- BMI ≥27kg/m2
- At least one self reported unsuccessful dietary effort to reduce body weight
- Not diabetic
- Planned or prior surgery for obesity (some exceptions)
- No active cancer or history of cancer in last 5 years (some exceptions)
- Not using Mounjaro/Ozempic type medications for at least 90 days prior to screening
Outpatient Visit
- Screening Visit
- Clinic visit every 4 weeks
Information for Practitioners
- Renal impairment eGFR <30mL/min/1.73m2
- Evidence of autoimmune disease with treatment of systemic glucorticoids
- History of MI, CVA, Angina, revascularisation, heart failure hospitalisation within 90 days of screening
- No history of unstable mental health disorder within last 2 years